European Medicines Agency to review EC

Beginning in January 2014, the European Medicines Agency (EMA) started reviewing emergency contraceptives to assess whether increased body weight and body mass index (BMI) reduce the efficacy of these medications. Based on the results of this review, EMA will assess whether any changes should be made to the product information for emergency contraceptives containing levonorgestrel or ulipristal acetate. For further information, read the EMA press release.

Similar Posts